OssDsign AB (OSSD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OssDsign AB (OSSD) has a cash flow conversion efficiency ratio of -0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-14.87 Million ≈ $-1.60 Million USD) by net assets (Skr298.87 Million ≈ $32.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OSSD equity financing ratio to measure how much of total assets are equity-financed.
OssDsign AB - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how OssDsign AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check OSSD cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
OssDsign AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OssDsign AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Texton Property Fund Ltd
JSE:TEX
|
0.095x |
|
Spectral AI Inc.
NASDAQ:MDAI
|
0.305x |
|
Ado Optronics
TWO:3516
|
0.009x |
|
Rapala VMC Oyj
HE:RAP1V
|
0.083x |
|
Simula Technology
TWO:3511
|
0.003x |
|
Grand Hall Enterprise Co Ltd
TWO:8941
|
0.077x |
|
Lion Chemtech Co. Ltd
KQ:171120
|
-0.035x |
|
Dongbang Agro
KO:007590
|
-0.150x |
Annual Cash Flow Conversion Efficiency for OssDsign AB (2017–2025)
The table below shows the annual cash flow conversion efficiency of OssDsign AB from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see how much is OssDsign AB worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr310.03 Million ≈ $33.36 Million |
Skr-64.03 Million ≈ $-6.89 Million |
-0.207x | +29.12% |
| 2024-12-31 | Skr214.06 Million ≈ $23.04 Million |
Skr-62.38 Million ≈ $-6.71 Million |
-0.291x | +22.07% |
| 2023-12-31 | Skr251.13 Million ≈ $27.03 Million |
Skr-93.91 Million ≈ $-10.11 Million |
-0.374x | -3.98% |
| 2022-12-31 | Skr248.11 Million ≈ $26.70 Million |
Skr-89.23 Million ≈ $-9.60 Million |
-0.360x | -5.23% |
| 2021-12-31 | Skr262.72 Million ≈ $28.27 Million |
Skr-89.78 Million ≈ $-9.66 Million |
-0.342x | +51.58% |
| 2020-12-31 | Skr112.07 Million ≈ $12.06 Million |
Skr-79.10 Million ≈ $-8.51 Million |
-0.706x | -10.26% |
| 2019-12-31 | Skr135.28 Million ≈ $14.56 Million |
Skr-86.59 Million ≈ $-9.32 Million |
-0.640x | +53.98% |
| 2018-12-31 | Skr47.49 Million ≈ $5.11 Million |
Skr-66.05 Million ≈ $-7.11 Million |
-1.391x | -72.66% |
| 2017-12-31 | Skr50.42 Million ≈ $5.43 Million |
Skr-40.61 Million ≈ $-4.37 Million |
-0.806x | -- |
About OssDsign AB
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. It offers OssDsign Catalyst, a nanosynthetic bone graft for dual bone formation pathways through fusion mass. The company was founded in 2011 and is headquartered in Uppsala, Sweden.